Cigna Group
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: February 27, 2025
| THE CIGNA GROUP | |
| By: | /s/ Brian C. Evanko |
| Brian C. Evanko | |
| Executive Vice President, Chief Financial Officer, The Cigna Group, and President and Chief Executive Officer, Cigna Healthcare | |
| (Principal Financial Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated as of February 27, 2025.
| Signature | Title |
|---|---|
| /s/ David M. Cordani | |
| David M. Cordani | Chairman and Chief Executive Officer of The Cigna Group |
| (Principal Executive Officer) | |
| /s/ Brian C. Evanko | |
| Brian C. Evanko | Executive Vice President, Chief Financial Officer, The Cigna Group, and President and Chief Executive Officer, Cigna Healthcare |
| (Principal Financial Officer) | |
| /s/ Jamie Kates | |
| Jamie Kates | Vice President and Global Chief Accounting Officer |
| (Principal Accounting Officer) | |
| /s/ William J. DeLaney | |
| William J. DeLaney | Director |
| /s/ Eric J. Foss | |
| Eric J. Foss | Director |
| /s/ Elder Granger, M.D. | |
| Elder Granger, M.D. | Director |
| /s/ Neesha Hathi | |
| Neesha Hathi | Director |
| /s/ George Kurian | |
|---|---|
| George Kurian | Director |
| /s/ Kathleen M. Mazzarella | |
| Kathleen M. Mazzarella | Director |
| /s/ Mark B. McClellan, M.D., Ph.D. | |
| Mark B. McClellan, M.D., Ph.D. | Director |
| /s/ Philip O. Ozuah, M.D., Ph.D. | |
| Philip O. Ozuah, M.D., Ph.D. | Director |
| /s/ Kimberly A. Ross | |
| Kimberly A. Ross | Director |
| /s/ Eric C. Wiseman | |
| Eric C. Wiseman | Lead Independent Director |
| /s/ Donna F. Zarcone | |
| Donna F. Zarcone | Director |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.